{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:32:11Z","timestamp":1787506331076,"version":"build-2736575974"},"reference-count":55,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,22]],"date-time":"2023-07-22T00:00:00Z","timestamp":1689984000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100014382","name":"Ipsen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014382","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001232","name":"Royal Australasian College of Physicians","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001232","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007075","name":"European Society for Medical Oncology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007075","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["esmoopen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["ESMO Open"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.esmoop.2023.101619","type":"journal-article","created":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T09:07:45Z","timestamp":1692868065000},"page":"101619","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Defining a role for systemic chemotherapy in local and advanced appendix adenocarcinoma"],"prefix":"10.1016","volume":"8","author":[{"given":"M.C.","family":"Strach","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Chakrabarty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.T.","family":"Nagaraju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Mullamitha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Braun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.T.","family":"O\u2019Dwyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Aziz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Barriuso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.esmoop.2023.101619_bib1","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ejso.2007.04.002","article-title":"Appendiceal neoplasms and pseudomyxoma peritonei: a population based study","volume":"34","author":"Smeenk","year":"2008","journal-title":"Eur J Surg Oncol"},{"issue":"12","key":"10.1016\/j.esmoop.2023.101619_bib2","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.1002\/cncr.10589","article-title":"Primary malignant neoplasms of the appendix: a population-based study from the surveillance, epidemiology and end-results program, 1973-1998","volume":"94","author":"McCusker","year":"2002","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.esmoop.2023.101619_bib3","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1111\/his.13324","article-title":"The histopathological classification, diagnosis and differential diagnosis of mucinous appendiceal neoplasms, appendiceal adenocarcinomas and pseudomyxoma peritonei","volume":"71","author":"Carr","year":"2017","journal-title":"Histopathology"},{"issue":"12","key":"10.1016\/j.esmoop.2023.101619_bib4","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1097\/00000478-199512000-00006","article-title":"Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. A clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to \u201cpseudomyxoma peritonei\u201d","volume":"19","author":"Ronnett","year":"1995","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.esmoop.2023.101619_bib5","first-page":"225","article-title":"Cancer statistics, 2009","volume":"59","author":"Jemal","year":"2009","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"10.1016\/j.esmoop.2023.101619_bib6","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1245\/s10434-015-4995-0","volume":"23","author":"Ihemelandu","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10.1016\/j.esmoop.2023.101619_bib7","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.ejso.2010.01.006","article-title":"Pseudomyxoma peritonei: a French multicentric study of 301 patients treated with cytoreductive surgery and intraperitoneal chemotherapy","volume":"36","author":"Elias","year":"2010","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"10.1016\/j.esmoop.2023.101619_bib8","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s11605-019-04336-4","article-title":"Should we be doing cytoreductive surgery with HIPEC for signet ring cell appendiceal adenocarcinoma? A study from the US HIPEC Collaborative","volume":"24","author":"Levinsky","year":"2020","journal-title":"J\u00a0Gastrointest Surg"},{"key":"10.1016\/j.esmoop.2023.101619_bib9","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.ejso.2020.08.017","article-title":"Comparative study of mucinous and non-mucinous appendiceal neoplasms with peritoneal dissemination treated by cyoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC)","volume":"47","author":"Garach","year":"2021","journal-title":"Eur J Surg Oncol"},{"issue":"2","key":"10.1016\/j.esmoop.2023.101619_bib10","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1245\/s10434-018-7007-3","article-title":"Outcomes in peritoneal dissemination from signet ring cell carcinoma of the appendix treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"26","author":"Munoz-Zuluaga","year":"2019","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"10.1016\/j.esmoop.2023.101619_bib11","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.ejso.2019.05.008","article-title":"Systemic chemotherapy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS\/HIPEC) in patients with high-grade mucinous carcinoma peritonei of appendiceal origin","volume":"45","author":"Munoz-Zuluaga","year":"2019","journal-title":"Eur J Surg Oncol"},{"issue":"11","key":"10.1016\/j.esmoop.2023.101619_bib12","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1038\/modpathol.2014.37","article-title":"Clinicopathologic and molecular analysis of disseminated appendiceal mucinous neoplasms: identification of factors predicting survival and proposed criteria for a three-tiered assessment of tumor grade","volume":"27","author":"Davison","year":"2014","journal-title":"Modern Pathol"},{"key":"10.1016\/j.esmoop.2023.101619_bib13","unstructured":"IARC. WHO Classification of Tumors of the Digestive System: Adenocarcinoma of the Appendix. 2019. Available at https:\/\/tumourclassification.iarc.who.int\/chaptercontent\/31\/42. Accessed April 8, 2022."},{"issue":"1","key":"10.1016\/j.esmoop.2023.101619_bib14","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/PAP.0000000000000178","article-title":"An update on the diagnosis, grading, and staging of appendiceal mucinous neoplasms","volume":"25","author":"Valasek","year":"2018","journal-title":"Adv Anat Pathol"},{"key":"10.1016\/j.esmoop.2023.101619_bib15","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/PAS.0000000000000535","article-title":"A\u00a0consensus for classification and pathologic reporting of pseudomyxoma peritonei and associated appendiceal neoplasia: the results of the Peritoneal Surface Oncology Group International (PSOGI) modified Delphi process","volume":"40","author":"Carr","year":"2016","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.esmoop.2023.101619_bib16","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00000658-199501000-00004","article-title":"Peritonectomy procedures","volume":"221","author":"Sugarbaker","year":"1995","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.esmoop.2023.101619_bib17","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S1470-2045(05)70539-8","article-title":"New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome?","volume":"7","author":"Sugarbaker","year":"2006","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.esmoop.2023.101619_bib18","series-title":"Peritoneal Carcinomatosis: Principles of Management","article-title":"Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis","author":"Jacquet","year":"1996"},{"issue":"3","key":"10.1016\/j.esmoop.2023.101619_bib19","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1053\/ejso.2000.1038","article-title":"Cytoreductive surgery and peri-operative intraperitoneal chemotherapy as a curative approach to pseudomyxoma peritonei syndrome","volume":"27","author":"Sugarbaker","year":"2001","journal-title":"Eur J Surg Oncol"},{"issue":"2","key":"10.1016\/j.esmoop.2023.101619_bib20","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/SLA.0b013e3182602ad2","article-title":"Inflammatory markers in blood and serum tumor markers predict survival in patients with epithelial appendiceal neoplasms undergoing surgical cytoreduction and intraperitoneal chemotherapy","volume":"256","author":"Chua","year":"2012","journal-title":"Ann Surg"},{"issue":"13","key":"10.1016\/j.esmoop.2023.101619_bib21","doi-asserted-by":"crossref","first-page":"4218","DOI":"10.1245\/s10434-014-3869-1","article-title":"Predictive and prognostic survival factors in peritoneal carcinomatosis from appendiceal cancer after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy","volume":"21","author":"Jimenez","year":"2014","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"10.1016\/j.esmoop.2023.101619_bib22","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1097\/DCR.0000000000001076","article-title":"Predicting survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for appendix adenocarcinoma","volume":"61","author":"Aziz","year":"2018","journal-title":"Dis Colon Rectum"},{"issue":"8","key":"10.1016\/j.esmoop.2023.101619_bib23","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1634\/theoncologist.2014-0294","article-title":"Hyperthermic intraperitoneal chemotherapy following cytoreductive surgery improves outcome in patients with primary appendiceal mucinous adenocarcinoma: a pooled analysis from three tertiary care centers","volume":"20","author":"Shaib","year":"2015","journal-title":"Oncol"},{"issue":"3","key":"10.1016\/j.esmoop.2023.101619_bib24","doi-asserted-by":"crossref","DOI":"10.1001\/jamasurg.2020.6363","article-title":"The role of hyperthermic intraperitoneal chemotherapy in pseudomyxoma peritonei after cytoreductive surgery","volume":"156","author":"Kusamura","year":"2021","journal-title":"JAMA Surg"},{"issue":"8","key":"10.1016\/j.esmoop.2023.101619_bib25","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1634\/theoncologist.2014-0106","article-title":"FOLFOX-4 chemotherapy for patients with unresectable or relapsed peritoneal pseudomyxoma","volume":"19","author":"Pietrantonio","year":"2014","journal-title":"Oncologist"},{"issue":"2","key":"10.1016\/j.esmoop.2023.101619_bib26","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/cncr.29744","article-title":"The impact of stage, grade, and mucinous histology on the efficacy of systemic chemotherapy in adenocarcinomas of the appendix: analysis of the National Cancer Data Base","volume":"122","author":"Asare","year":"2016","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.esmoop.2023.101619_bib27","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.ejso.2015.01.005","article-title":"Systemic chemotherapy (SC) before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS\/HIPEC) in patients with peritoneal mucinous carcinomatosis of appendiceal origin (PMCA)","volume":"41","author":"Milovanov","year":"2015","journal-title":"Eur J Surg Oncol"},{"issue":"7","key":"10.1016\/j.esmoop.2023.101619_bib28","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1002\/jso.23547","article-title":"Perioperative systemic chemotherapy for appendiceal mucinous carcinoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"109","author":"Blackham","year":"2014","journal-title":"J\u00a0Surg Oncol"},{"issue":"2","key":"10.1016\/j.esmoop.2023.101619_bib29","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"issue":"5","key":"10.1016\/j.esmoop.2023.101619_bib30","doi-asserted-by":"crossref","first-page":"e780","DOI":"10.1002\/onco.13707","article-title":"College of American Pathologists tumor regression grading system for long-term outcome in patients with locally advanced rectal cancer","volume":"26","author":"Chen","year":"2021","journal-title":"Oncologist"},{"issue":"11","key":"10.1016\/j.esmoop.2023.101619_bib31","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1097\/DCR.0000000000000869","article-title":"Peritoneal involvement is more common than nodal involvement in patients with high-grade appendix tumors who are undergoing prophylactic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"60","author":"Mehta","year":"2017","journal-title":"Dis Colon Rectum"},{"issue":"4","key":"10.1016\/j.esmoop.2023.101619_bib32","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1245\/s10434-021-10994-z","article-title":"Overall survival is more closely associated with peritoneal than primary appendiceal pathological grade in pseudomyxoma peritonei with discordant pathology","volume":"29","author":"Memon","year":"2022","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"10.1016\/j.esmoop.2023.101619_bib33","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1136\/jclinpath-2012-200843","article-title":"Pathology and prognosis in pseudomyxoma peritonei: a review of 274 cases","volume":"65","author":"Carr","year":"2012","journal-title":"J\u00a0Clin Pathol"},{"issue":"1","key":"10.1016\/j.esmoop.2023.101619_bib34","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ejso.2020.10.020","article-title":"Long-term outcomes for patients with peritoneal acellular mucinosis secondary to low grade appendiceal mucinous neoplasms","volume":"47","author":"Evans","year":"2021","journal-title":"Eur J Surg Oncol"},{"issue":"6","key":"10.1016\/j.esmoop.2023.101619_bib35","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1002\/jso.25379","article-title":"Signet ring cell features with peritoneal carcinomatosis in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy are associated with poor overall survival","volume":"119","author":"Solomon","year":"2019","journal-title":"J\u00a0Surg Oncol"},{"issue":"5","key":"10.1016\/j.esmoop.2023.101619_bib36","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1245\/s10434-014-3985-y","article-title":"Predictors of progression in high-grade appendiceal or colorectal peritoneal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"22","author":"Baumgartner","year":"2015","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.esmoop.2023.101619_bib37","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/jso.26493","article-title":"Lymph node positivity and association with long-term survival for different histologies of appendiceal cancer","volume":"124","author":"Webb","year":"2021","journal-title":"J\u00a0Surg Oncol"},{"issue":"3","key":"10.1016\/j.esmoop.2023.101619_bib38","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/bjs.4393","article-title":"Right hemicolectomy does not confer a survival advantage in patients with mucinous carcinoma of the appendix and peritoneal seeding","volume":"91","author":"Gonz\u00e1lez-Moreno","year":"2004","journal-title":"Brit J Surg"},{"issue":"7","key":"10.1016\/j.esmoop.2023.101619_bib39","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.ejso.2017.01.009","article-title":"Long-term regional chemotherapy for patients with epithelial malignant peritoneal mesothelioma results in improved survival","volume":"43","author":"Sugarbaker","year":"2017","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.esmoop.2023.101619_bib40","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1245\/s10434-021-11213-5","article-title":"Pathologic factors associated with low risk of lymph node metastasis in nonmucinous adenocarcinoma of the appendix","volume":"29","author":"Straker","year":"2022","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.esmoop.2023.101619_bib41","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/DCR.0000000000002089","article-title":"Appendectomy is oncologically equivalent to right hemicolectomy for well differentiated T1 appendiceal adenocarcinoma","volume":"66","author":"AlMasri","year":"2023","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.esmoop.2023.101619_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/17588359221112478","article-title":"The role of chemotherapy in the treatment of advanced appendiceal cancers: summary of the literature and future directions","volume":"14","author":"Strach","year":"2022","journal-title":"Ther Adv Med Oncol"},{"issue":"3","key":"10.1016\/j.esmoop.2023.101619_bib43","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/jso.25599","article-title":"Systemic chemotherapy and survival in patients with metastatic low-grade appendiceal mucinous adenocarcinoma","volume":"120","author":"Lu","year":"2019","journal-title":"J\u00a0Surg Oncol"},{"issue":"4","key":"10.1016\/j.esmoop.2023.101619_bib44","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1093\/annonc\/mdu031","article-title":"Perioperative systemic chemotherapy in peritoneal carcinomatosis of lymph node positive colorectal cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"25","author":"Kuijpers","year":"2014","journal-title":"Ann Oncol"},{"issue":"3","key":"10.1016\/j.esmoop.2023.101619_bib45","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1093\/annonc\/mdr279","article-title":"Systemic chemotherapy and\u00a0surgical cytoreduction for poorly differentiated and signet ring cell adenocarcinomas of the appendix","volume":"23","author":"Lieu","year":"2012","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1016\/j.esmoop.2023.101619_bib46","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/cncr.24715","article-title":"Modern systemic chemotherapy in surgically unresectable neoplasms of appendiceal origin: a single-institution experience","volume":"116","author":"Shapiro","year":"2010","journal-title":"Cancer"},{"issue":"8","key":"10.1016\/j.esmoop.2023.101619_bib47","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.6004\/jnccn.2014.0109","article-title":"Systemic therapy for advanced appendiceal adenocarcinoma: an analysis from the NCCN Oncology Outcomes Database for colorectal cancer","volume":"12","author":"Tejani","year":"2014","journal-title":"J\u00a0Natl Compr Canc Netw"},{"issue":"4","key":"10.1016\/j.esmoop.2023.101619_bib48","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1245\/s10434-012-2789-1","article-title":"Assessment of neoadjuvant chemotherapy on operative parameters and outcome in patients with peritoneal dissemination from high-grade appendiceal cancer","volume":"20","author":"Turner","year":"2013","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.esmoop.2023.101619_bib49","first-page":"e179","article-title":"Metronomic capecitabine with cyclophosphamide regimen in unresectable or relapsed pseudomyxoma peritonei","volume":"18","author":"Raimondi","year":"2019","journal-title":"Clin Colorectal Canc"},{"issue":"12","key":"10.1016\/j.esmoop.2023.101619_bib50","first-page":"1","article-title":"Systemic chemotherapy prior to cytoreductive surgery and HIPEC for carcinomatosis from appendix cancer: impact on perioperative outcomes and short-term survival","volume":"2012","author":"Bijelic","year":"2012","journal-title":"Gastroent Res Pract"},{"issue":"6","key":"10.1016\/j.esmoop.2023.101619_bib51","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1002\/jso.21679","article-title":"Neoadjuvant FOLFOX chemotherapy in 34 consecutive patients with mucinous peritoneal carcinomatosis of appendiceal origin","volume":"102","author":"Sugarbaker","year":"2010","journal-title":"J\u00a0Surg Oncol"},{"issue":"8","key":"10.1016\/j.esmoop.2023.101619_bib52","doi-asserted-by":"crossref","first-page":"e2980","DOI":"10.1038\/cddis.2017.378","article-title":"MUC1 induces acquired chemoresistance by upregulating ABCB1 in EGFR-dependent manner","volume":"8","author":"Jin","year":"2017","journal-title":"Cell Death Dis"},{"issue":"2","key":"10.1016\/j.esmoop.2023.101619_bib53","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s10555-021-09959-1","article-title":"Mucins reprogram stemness, metabolism and promote chemoresistance during cancer progression","volume":"40","author":"Marimuthu","year":"2021","journal-title":"Cancer Metast Rev"},{"issue":"10","key":"10.1016\/j.esmoop.2023.101619_bib54","doi-asserted-by":"crossref","first-page":"3400","DOI":"10.1002\/cam4.3009","article-title":"Impact of adjuvant chemotherapy on outcomes in appendiceal cancer","volume":"9","author":"Kolla","year":"2020","journal-title":"Cancer Med"},{"issue":"4","key":"10.1016\/j.esmoop.2023.101619_bib55","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1245\/s10434-014-4147-y","article-title":"Peritoneal surface disease\u00a0(PSD) from appendiceal cancer treated with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC):\u00a0overview of 481 cases","volume":"22","author":"Votanopoulos","year":"2015","journal-title":"Ann Surg Oncol"}],"container-title":["ESMO Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2059702923008542?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2059702923008542?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T20:30:05Z","timestamp":1761856205000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2059702923008542"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":55,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S2059702923008542"],"URL":"https:\/\/doi.org\/10.1016\/j.esmoop.2023.101619","relation":{},"ISSN":["2059-7029"],"issn-type":[{"value":"2059-7029","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Defining a role for systemic chemotherapy in local and advanced appendix adenocarcinoma","name":"articletitle","label":"Article Title"},{"value":"ESMO Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.esmoop.2023.101619","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd on behalf of European Society for Medical Oncology.","name":"copyright","label":"Copyright"}],"article-number":"101619"}}